Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Respiratory depression with opioids.

Albert Dahan1

  • 1Leiden University Medical Center, Leiden University, The Netherlands. a.dahan@lumc.nl

Journal of Pain & Palliative Care Pharmacotherapy
|April 14, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of Selective Sphingosine-1-Phosphate Receptor 1 Agonist, TRV045, on Evoked Pain Tests: An Exploratory, Four-Way Cross-Over Study in Healthy Volunteers.

European journal of pain (London, England)·2026
Same author

Combination of the BK-Channel Antagonist ENA-001 and Naloxone Is More Effective Than Either Agent Alone in Reversing Fentanyl-Induced Respiratory Suppression in Rats.

Cureus·2026
Same author

Corrigendum to 'Morphine and hydromorphone pharmacodynamics in human volunteers: population-based modelling of interindividual response variability and utility' (Br J Anaesth 2026; 136: 1459-71).

British journal of anaesthesia·2026
Same author

Factors Associated With Concurrent Benzodiazepine and Opioid Use Following Total Hip and Knee Arthroplasty: A Nationwide Cohort Study.

Pharmacoepidemiology and drug safety·2026
Same author

<i>In Vivo</i> Detection of Nitrous Oxide in Blood and Saliva Following Recreational Use.

ACS omega·2026
Same author

Effect of Paroxetine or Escitalopram Coadministered with Oxycodone versus Oxycodone Alone on Ventilation during Hypercapnia: A Randomized Clinical Trial.

Anesthesiology·2026
Same journal

Cancer Patients with Neuropathic Pain: Pharmacist-Led Recommendation and Management and Mirogabalin Outcomes in a Single-Center Retrospective Observational Cohort.

Journal of pain & palliative care pharmacotherapy·2026
Same journal

Cost-Effectiveness of Integrative Pain Management for Chronic Pain: A Systematic Review of Economic Evaluation.

Journal of pain & palliative care pharmacotherapy·2026
Same journal

High-Dose Monotherapy or Combination Therapy in Neuropathic Pain: A Necessary Reflection.

Journal of pain & palliative care pharmacotherapy·2026
Same journal

The Price of Goodbye.

Journal of pain & palliative care pharmacotherapy·2026
Same journal

In the End, What Shall We Say?

Journal of pain & palliative care pharmacotherapy·2026
Same journal

The Use of Ketamine for Depression in Cancer Patients: A Systematic Review of Efficacy, Safety, and Clinical Applications.

Journal of pain & palliative care pharmacotherapy·2026
See all related articles

Opioid-induced respiratory depression is a significant concern. This guide provides essential information on safe opioid use, encouraging clinicians to prescribe them when medically necessary.

Area of Science:

  • Medical Science
  • Pharmacology
  • Clinical Practice

Background:

  • Opioid medications are effective analgesics but carry risks.
  • Respiratory depression is a primary adverse effect of opioids.
  • Safe prescribing practices are crucial for patient safety.

Purpose of the Study:

  • To present guidelines for the safe administration of opioids.
  • To address clinician concerns regarding opioid-induced respiratory depression.
  • To promote appropriate opioid utilization in clinical settings.

Main Methods:

  • Review and synthesis of current clinical guidelines.
  • Evidence-based recommendations for opioid management.
  • Discussion of risk mitigation strategies.

Related Experiment Videos

Main Results:

  • Comprehensive guidelines for safe opioid prescribing are outlined.
  • Strategies to minimize the risk of respiratory depression are detailed.
  • Emphasis on clinical indication for opioid therapy.

Conclusions:

  • Clinicians should not hesitate to use opioids when clinically indicated.
  • Adherence to safe use guidelines can mitigate risks.
  • Optimizing opioid therapy balances efficacy and safety.